loader

BELLUS Health Inc.

TSX:BLU
Featured Articles and Interviews
Press Releases

BLUENERGIES LTD. ANNOUNCES COMMENCEMENT OF TRADING ON THE TSX VENTURE EXCHANGE

BluEnrgies Ltd. Announces Closing of Reverse Takeover Transaction

BELLUS Health Reports First Quarter 2023 Financial Results and Business Highlights

BELLUS Health Inc is a clinical-stage biopharmaceutical development company advancing novel therapeutics for conditions with a high unmet medical need, including BLU-5937, P2X3 antagonist that has the potential to be a best-in-class therapeutic for chronic cough. The company operates in one business segment namely, the development of drug candidates for health solutions.

Interactive Chart

×